Kemble George
SEC CIK 1858176 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SGMT | Sagimet Biosciences Inc. | Executive COB, Dir | 413.1K | — | $4.34M | 10 | 2023-09-07 | 2026-08-14 |
Most active insiders at SGMT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kemble George | Executive COB, Dir | — | $4.22M |
| 2 | Happel David | Pres, CEO, Dir | — | $561.9K |
| 3 | Rozek Elizabeth | Chief Legal, Admin. Off | — | $95.9K |
| 4 | Martins Eduardo Bruno | Chief Medical Off | — | $19.5K |
| 5 | Chauche Thierry | CFO | — | $7,032 |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-17 16:05 | 2026-08-14 | SGMT | Sagimet Biosciences Inc. | Kemble George | Dir | M - OptEx | $6.36 | +351.0K | 413.1K | +565% | +$2.23M |
| DT | 2026-08-17 16:05 | 2026-08-14 | SGMT | Sagimet Biosciences Inc. | Kemble George | Dir | S - Sale+OE | $10.23 | -351.0K | 62.2K | -85% | -$3.59M |
| DMT | 2026-08-12 19:41 | 2026-08-11 | SGMT | Sagimet Biosciences Inc. | Kemble George | Dir | M - OptEx | $6.36 | +20.2K | 82.4K | +33% | +$128.5K |
| DT | 2026-08-12 19:41 | 2026-08-11 | SGMT | Sagimet Biosciences Inc. | Kemble George | Dir | S - Sale+OE | $9.95 | -20.2K | 62.2K | -25% | -$201.1K |
| T | 2026-07-22 16:05 | 2026-07-20 | SGMT | Sagimet Biosciences Inc. | Kemble George | Dir | S - Sale | $7.46 | -18.8K | 62.2K | -23% | -$140.5K |
| 2025-11-21 | 2025-11-20 | SGMT | Sagimet Biosciences Inc. | Kemble George | Executive COB, Dir | S - Sale | $7.69 | -37.7K | 81.0K | -32% | -$289.8K | |
| 2024-07-25 | 2024-07-23 | SGMT | Sagimet Biosciences Inc. | Kemble George | Executive COB, Dir | S - Sale | $3.17 | -23.6K | 118.7K | -17% | -$74.9K | |
| 2024-07-23 | 2024-07-19 | SGMT | Sagimet Biosciences Inc. | Kemble George | Executive COB, Dir | S - Sale | $3.10 | -14.1K | 142.3K | -9% | -$43.6K | |
| 2023-11-21 | 2023-11-17 | SGMT | Sagimet Biosciences Inc. | Kemble George | Executive COB, Dir | A - Grant | $0.00 | +150.8K | 156.4K | +2,678% | $0 | |
| D | 2023-09-08 | 2023-09-07 | SGMT | Sagimet Biosciences Inc. | Kemble George | Executive COB, Dir | M - OptEx | $0.79 | +5,630 | 5,630 | New | +$4,448 |
Purchase Sale Sale after option exercise All abbreviations